Personalized Sequence for Thoracic, Esophageal, and H&N Cancer
NCT02299622 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-03-19
Summary
The next generation of personalized medical treatment according to the type of personal genetic information are evolving rapidly. The genome analysis needs systematic infra and database based on personal genetic information Therefore, a big data of genome-clinical information is important.
Conditions
Interventions
- GENETIC
-
Genetic test
Next-generation sequencing (AmpliSeq) \& fusion analysis
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Principal Investigators
-
Keunchil Park · Samsung Medical Center
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2022-11-30
- Completion
- 2023-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer
NCT02067754 ·Status: COMPLETED
-
Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea
NCT02538562 ·Status: COMPLETED
-
Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics
NCT05269056 ·Status: UNKNOWN
-
Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer
NCT01831609 ·Status: UNKNOWN
-
Genetic Characteristics of Metastatic Breast Cancer Patients
NCT04258735 ·Status: UNKNOWN ·Phase: NA
-
Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer
NCT02597179 ·Status: UNKNOWN
-
Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma
NCT01482520 ·Status: COMPLETED
-
Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples
NCT01792882 ·Status: WITHDRAWN
-
Cancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030
NCT00899535 ·Status: COMPLETED
-
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
NCT02566421 ·Status: TERMINATED ·Phase: NA
-
Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection
NCT06895551 ·Status: COMPLETED
-
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486 ·Status: RECRUITING
-
Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer
NCT02273336 ·Status: COMPLETED
-
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
NCT07035587 ·Status: RECRUITING
-
Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment
NCT02297087 ·Status: TERMINATED ·Phase: NA
-
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
NCT02178163 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
NCT00242723 ·Status: RECRUITING
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell Lymphoma
NCT01606605 ·Status: COMPLETED
-
Cancer Genome Analysis
NCT01458704 ·Status: UNKNOWN
-
Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
NCT00899405 ·Status: RECRUITING
-
Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer
NCT00963326 ·Status: UNKNOWN
-
Testing BRCA 1/2 Mutation Using Next Generation Sequencing
NCT02151747 ·Status: COMPLETED
-
Biomarker Research for Personalized Medicine
NCT01488591 ·Status: UNKNOWN
-
Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
NCT02628379 ·Status: COMPLETED